Skip to main content
Top
Published in: Acta Neurologica Belgica 4/2013

01-12-2013 | Original Article

Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients

Authors: Petar Filipović Grčić, Meri Matijaca, Ivica Bilić, Gordan Džamonja, Ivo Lušić, Krešimir Čaljkušić, Vesna Čapkun

Published in: Acta Neurologica Belgica | Issue 4/2013

Login to get access

Abstract

Walking limitation assessment in multiple sclerosis patients (MSPs) is a demanding task, especially in the clinical setting. The aim of this study is to correlate the visual analogue scale (VAS), a simple method for measuring subjective experience, with measures of walking ability used in clinical research of MS. The study included 82 ambulatory MSPs who have resided in the local community. The applied measures of walking ability were the following: the single-item and patient-rated Walking Ability Visual Analogue Scale (WA-VAS), the Expanded Disability Status Scale (EDSS), the 25-foot walk test (25FWT), the Six Spot Step Test (SSST), the 2 min timed walk (2 min TW), the Multiple Sclerosis Walking Scale-12 (MSWS-12), and step activity monitor accelerometer (SAM) during 7 day period. The SAM analysis included the average daily step count, the average steps/min of the highest 1 min of a day, and the average steps/min of the highest continuous 60 min of a day. The WA-VAS scores significantly and strongly correlated with EDSS (ρ = 0.679, P < 0.001), 25FWT (ρ = 0.606, P < 0.001), SSST (ρ = 0.729, P < 0.001), 2 min TW (ρ = −0.643, P < 0.001), MSWS-12 (ρ = 0.746, P < 0.001), average daily step count (ρ = –0.507, P < 0.001), average steps/min of the highest 1 min of a day (ρ = –0.544, P < 0.001), and average steps/min of the highest continuous 60 min of a day (ρ = −0.473, P < 0.001). Correlations between WA-VAS and measures of walking ability used in clinical research of MS were satisfactory. The results obtained in this research indicate that the WA-VAS could be an instrument for simple measurement of walking limitations in MSPs in the clinical setting.
Literature
1.
go back to reference Swingler R, Compston DAS (1992) The morbidity of multiple sclerosis. Q J Med 83:325–337PubMed Swingler R, Compston DAS (1992) The morbidity of multiple sclerosis. Q J Med 83:325–337PubMed
2.
go back to reference Hobart JC, Lamping DL, Fitzpatrick R et al (2001) The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain 124:962–973PubMedCrossRef Hobart JC, Lamping DL, Fitzpatrick R et al (2001) The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain 124:962–973PubMedCrossRef
3.
go back to reference Heesen C, Bohm J, Reich C et al (2008) Patient perception of bodily function in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 14:988–991PubMedCrossRef Heesen C, Bohm J, Reich C et al (2008) Patient perception of bodily function in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 14:988–991PubMedCrossRef
4.
go back to reference Pearson OR, Busse ME, van Deursen RWM, Wiles CM (2004) Quantification of walking mobility in neurological disorders. Q J Med 97:463–475CrossRef Pearson OR, Busse ME, van Deursen RWM, Wiles CM (2004) Quantification of walking mobility in neurological disorders. Q J Med 97:463–475CrossRef
5.
go back to reference Bethoux F, Bennett S (2011) Evaluating walking in patients with multiple sclerosis. Which assessment tools are useful in clinical practice? Int J MS Care 13:4–13CrossRef Bethoux F, Bennett S (2011) Evaluating walking in patients with multiple sclerosis. Which assessment tools are useful in clinical practice? Int J MS Care 13:4–13CrossRef
6.
go back to reference Hasson D, Arnetz BB (2005) Validation and findings comparing VAS vs. Likert scales for psychosocial measurements. Int Electron J Health Educ 8:178–192 Hasson D, Arnetz BB (2005) Validation and findings comparing VAS vs. Likert scales for psychosocial measurements. Int Electron J Health Educ 8:178–192
7.
go back to reference Wewers ME, Lowe NK (1990) A critical review of visual analogue scale in the measurement of clinical phenomena. Res Nurs Health 13:227–236PubMedCrossRef Wewers ME, Lowe NK (1990) A critical review of visual analogue scale in the measurement of clinical phenomena. Res Nurs Health 13:227–236PubMedCrossRef
8.
go back to reference Kempen JC, de Groot V, Knol DL, Lankhorst GJ, Beckerman H (2012) Self-reported fatigue and energy cost during walking are not related in patients with multiple sclerosis. Arch Phys Med Rehabil 93:889–895PubMedCrossRef Kempen JC, de Groot V, Knol DL, Lankhorst GJ, Beckerman H (2012) Self-reported fatigue and energy cost during walking are not related in patients with multiple sclerosis. Arch Phys Med Rehabil 93:889–895PubMedCrossRef
9.
go back to reference Wade DT, Collin C, Stott C, Duncombe P (2010) Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 16:707–714PubMedCrossRef Wade DT, Collin C, Stott C, Duncombe P (2010) Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 16:707–714PubMedCrossRef
10.
go back to reference Aragona M, Onesti E, Tomassini V et al (2009) Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Clin Neuropharmacol 32:41–47PubMed Aragona M, Onesti E, Tomassini V et al (2009) Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Clin Neuropharmacol 32:41–47PubMed
11.
go back to reference Zecca C, Petrini L, Limoni C, Staedler Gobbi C (2011) Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis. Eur Neurol 65:40–45PubMedCrossRef Zecca C, Petrini L, Limoni C, Staedler Gobbi C (2011) Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis. Eur Neurol 65:40–45PubMedCrossRef
12.
go back to reference Simsarian JP, Saunders C, Smith DM (2011) Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomised, open-label pilot trail. Drug Des Dev Ther 5:381–389CrossRef Simsarian JP, Saunders C, Smith DM (2011) Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomised, open-label pilot trail. Drug Des Dev Ther 5:381–389CrossRef
13.
go back to reference Richette P, Hilliquin P, Bertin P, Carni P, Berger V, Marty M (2011) Comparison of general practitioners and rheumatologists prescription patterns for patients with knee osteoarthritis. BMC Musculoscelet Disord 12:72CrossRef Richette P, Hilliquin P, Bertin P, Carni P, Berger V, Marty M (2011) Comparison of general practitioners and rheumatologists prescription patterns for patients with knee osteoarthritis. BMC Musculoscelet Disord 12:72CrossRef
14.
go back to reference Tomilson D, Bartels U, Hendershot E, Maloney AM, Ethier MC, Sung L (2011) Factors affecting treatment choices in paediatric palliative care: comparing parents and health professionals. Eur J Cancer 47:2182–2187CrossRef Tomilson D, Bartels U, Hendershot E, Maloney AM, Ethier MC, Sung L (2011) Factors affecting treatment choices in paediatric palliative care: comparing parents and health professionals. Eur J Cancer 47:2182–2187CrossRef
15.
go back to reference Bijlenga D, Birnie E, Motl BW, Bonsel GJ (2011) Obstetrical outcome valuations by patients, professionals, and laypersons: differences within and between groups using three valuation methods. BMC Pregnancy Childbirth 11:93PubMedCrossRef Bijlenga D, Birnie E, Motl BW, Bonsel GJ (2011) Obstetrical outcome valuations by patients, professionals, and laypersons: differences within and between groups using three valuation methods. BMC Pregnancy Childbirth 11:93PubMedCrossRef
16.
go back to reference Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef
17.
go back to reference Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thomson AJ (2003) Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology 60:31–36PubMedCrossRef Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thomson AJ (2003) Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology 60:31–36PubMedCrossRef
18.
go back to reference Pearson OR, Musse ME, van Deursen R, Wiles CM (2003) Quantification of walking mobility in multiple sclerosis (MS) using an ambulatory activity monitor–a pilot study (abstract). J Neurol Neurosurg Psychiatry 74:1450 Pearson OR, Musse ME, van Deursen R, Wiles CM (2003) Quantification of walking mobility in multiple sclerosis (MS) using an ambulatory activity monitor–a pilot study (abstract). J Neurol Neurosurg Psychiatry 74:1450
19.
go back to reference Weikert M, Motl RW, Suh Y, McAuley E, Winn D (2010) Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility? J Neurol Sci 290:6–11PubMedCrossRef Weikert M, Motl RW, Suh Y, McAuley E, Winn D (2010) Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility? J Neurol Sci 290:6–11PubMedCrossRef
20.
go back to reference Motl RW, Snook EM, Agiovlastis S (2011) Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis? Disabil Health J 4:52–57PubMedCrossRef Motl RW, Snook EM, Agiovlastis S (2011) Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis? Disabil Health J 4:52–57PubMedCrossRef
21.
go back to reference Filipović Grčić P, Matijaca M, Lušić I, Čapkun V (2011) Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses. Med Sci Monit 17:704–710 Filipović Grčić P, Matijaca M, Lušić I, Čapkun V (2011) Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses. Med Sci Monit 17:704–710
22.
go back to reference Mc Donald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRef Mc Donald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRef
23.
go back to reference Cutter GR, Baier ML, Rudick RA et al (1999) Development of a multiple sclerosis functional composite as a clinical trail outcome measure. Brain 122:871–882PubMedCrossRef Cutter GR, Baier ML, Rudick RA et al (1999) Development of a multiple sclerosis functional composite as a clinical trail outcome measure. Brain 122:871–882PubMedCrossRef
24.
go back to reference Nieuwenhius MM, Van Tongren H, Sørensen PS, Ravnborg M (2006) The Six Spot Step Test: a new measurement for walking ability in multiple sclerosis. Mult Scler 12:495–500CrossRef Nieuwenhius MM, Van Tongren H, Sørensen PS, Ravnborg M (2006) The Six Spot Step Test: a new measurement for walking ability in multiple sclerosis. Mult Scler 12:495–500CrossRef
25.
go back to reference Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM (1982) Two-, six-, and 12-min walking tests in respiratory disease. Br Med J (Clin Res Ed) 284:1607–1608CrossRef Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM (1982) Two-, six-, and 12-min walking tests in respiratory disease. Br Med J (Clin Res Ed) 284:1607–1608CrossRef
26.
go back to reference Svensson E (2001) Construction of a single global scale for multi-item assessments of the same variable. Stat Med 20:3831–3846PubMedCrossRef Svensson E (2001) Construction of a single global scale for multi-item assessments of the same variable. Stat Med 20:3831–3846PubMedCrossRef
27.
go back to reference Svensson E (2000) Comparison of the quality of assessments using continuous and discrete ordinal rating scales. Biometr J 42:417–434CrossRef Svensson E (2000) Comparison of the quality of assessments using continuous and discrete ordinal rating scales. Biometr J 42:417–434CrossRef
28.
go back to reference Svensson E (2000) Concordance between ratings using different scale for the same variable. Stat Med 19:3483–3496PubMedCrossRef Svensson E (2000) Concordance between ratings using different scale for the same variable. Stat Med 19:3483–3496PubMedCrossRef
29.
go back to reference Svensson E (2001) Guidelines to statistical evaluation of data from rating scales and questionnaires. J Rehabil Med 33:47–48PubMedCrossRef Svensson E (2001) Guidelines to statistical evaluation of data from rating scales and questionnaires. J Rehabil Med 33:47–48PubMedCrossRef
30.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Erlmaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Erlmaum Associates, Hillsdale
31.
go back to reference Motl RW, Mc Auley E, Snook EM, Scott JA (2006) Validity of physical activity measures in ambulatory individuals with multiple sclerosis. Disabil Rehabil 28:1151–1156PubMedCrossRef Motl RW, Mc Auley E, Snook EM, Scott JA (2006) Validity of physical activity measures in ambulatory individuals with multiple sclerosis. Disabil Rehabil 28:1151–1156PubMedCrossRef
32.
go back to reference Gijbels G, Alders D, Van Hoof E et al (2010) Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 16:618–626PubMedCrossRef Gijbels G, Alders D, Van Hoof E et al (2010) Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 16:618–626PubMedCrossRef
33.
go back to reference Snook EM, Motl RW, Gliottoni RC (2009) The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis. Clin Rehabil 23:248–258PubMedCrossRef Snook EM, Motl RW, Gliottoni RC (2009) The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis. Clin Rehabil 23:248–258PubMedCrossRef
34.
go back to reference Murray CJL (2002) Summary measures of population health: concepts, ethics, measurement, and application. World Health Organisation, Geneva Murray CJL (2002) Summary measures of population health: concepts, ethics, measurement, and application. World Health Organisation, Geneva
35.
go back to reference van Learhoven H, van der Zaag-Loonen HJ, Derkx BH (2004) A comparison of Likert scale and visual analogue scale as response options in children’s questionnaires. Acta Paediatr 93:830–835CrossRef van Learhoven H, van der Zaag-Loonen HJ, Derkx BH (2004) A comparison of Likert scale and visual analogue scale as response options in children’s questionnaires. Acta Paediatr 93:830–835CrossRef
36.
go back to reference Bolton JE, Wilkinson RC (1998) Responsiveness of pain scale: a comparison of three pain intensity measures in chiropractic patients. Manipulative Physiol Ther 21:1–7 Bolton JE, Wilkinson RC (1998) Responsiveness of pain scale: a comparison of three pain intensity measures in chiropractic patients. Manipulative Physiol Ther 21:1–7
37.
go back to reference Paul-Dauphin A, Guillemin F, Virion JM, Briancon S (1999) Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol 150:1117–1127PubMedCrossRef Paul-Dauphin A, Guillemin F, Virion JM, Briancon S (1999) Bias and precision in visual analogue scales: a randomized controlled trial. Am J Epidemiol 150:1117–1127PubMedCrossRef
38.
go back to reference du Toit R, Pritchard N, Heffernan S, Simpson T, Fonn D (2002) A comparison of three different scales for rating contact lens handling. Optom Vis Sci 79:313–320PubMedCrossRef du Toit R, Pritchard N, Heffernan S, Simpson T, Fonn D (2002) A comparison of three different scales for rating contact lens handling. Optom Vis Sci 79:313–320PubMedCrossRef
39.
go back to reference Youngblut JM, Casper GR (1993) Single-item indicators in nursing research. Res Nurs Health 16:459–465PubMedCrossRef Youngblut JM, Casper GR (1993) Single-item indicators in nursing research. Res Nurs Health 16:459–465PubMedCrossRef
40.
go back to reference Messick S (1989) Validity. In: Linn RL (ed) Educational measurement, 3rd edn. Macmillan, NewYork, pp 13–103 Messick S (1989) Validity. In: Linn RL (ed) Educational measurement, 3rd edn. Macmillan, NewYork, pp 13–103
41.
go back to reference Motl RW, Snook EM, Mc Auley E et al (2007) Demographic correlates of physical activity in individuals with multiple sclerosis. Disabil Rehabil 29:1301–1304PubMedCrossRef Motl RW, Snook EM, Mc Auley E et al (2007) Demographic correlates of physical activity in individuals with multiple sclerosis. Disabil Rehabil 29:1301–1304PubMedCrossRef
42.
go back to reference Doerksen SE, Motl RW, Mc Auley E (2007) Environmental correlates of physical activity in multiple sclerosis: a cross-sectional study. Int J Behav Nutr Phys Act 4:49PubMedCrossRef Doerksen SE, Motl RW, Mc Auley E (2007) Environmental correlates of physical activity in multiple sclerosis: a cross-sectional study. Int J Behav Nutr Phys Act 4:49PubMedCrossRef
43.
go back to reference Joyce CR, Zutshi DW, Hrubes V, Mason RM (1975) Comparison of fixed interval and visual analogue scale for rating chronic pain. Eur J Clin Pharmacol 8:415–420PubMedCrossRef Joyce CR, Zutshi DW, Hrubes V, Mason RM (1975) Comparison of fixed interval and visual analogue scale for rating chronic pain. Eur J Clin Pharmacol 8:415–420PubMedCrossRef
44.
go back to reference Grunberg SM, Groshen S, Steingass S, Zaretsky S, Meyerowitz B (1996) Comparison of conditional quality of life terminology and visual analogue scale measurements. Qual Life Res 5:65–72PubMedCrossRef Grunberg SM, Groshen S, Steingass S, Zaretsky S, Meyerowitz B (1996) Comparison of conditional quality of life terminology and visual analogue scale measurements. Qual Life Res 5:65–72PubMedCrossRef
Metadata
Title
Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients
Authors
Petar Filipović Grčić
Meri Matijaca
Ivica Bilić
Gordan Džamonja
Ivo Lušić
Krešimir Čaljkušić
Vesna Čapkun
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Acta Neurologica Belgica / Issue 4/2013
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-013-0187-5

Other articles of this Issue 4/2013

Acta Neurologica Belgica 4/2013 Go to the issue